CSMMX
Price
$18.27
Change
-$1.32 (-6.74%)
Updated
Apr 3 closing price
Net Assets
3.07B
GFACX
Price
$57.16
Change
-$3.41 (-5.63%)
Updated
Apr 3 closing price
Net Assets
279.82B
Ad is loading...

CSMMX vs GFACX

Header iconCSMMX vs GFACX Comparison
Open Charts CSMMX vs GFACXBanner chart's image
Invesco Summit C
Price$18.27
Change-$1.32 (-6.74%)
VolumeN/A
Net Assets3.07B
American Funds Growth Fund of Amer C
Price$57.16
Change-$3.41 (-5.63%)
VolumeN/A
Net Assets279.82B
CSMMX vs GFACX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CSMMX vs. GFACX commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSMMX is a Hold and GFACX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 280B vs. CSMMX (3.08B). CSMMX (0.00) and GFACX (0.00) have matching dividends . CSMMX was incepted earlier than GFACX: CSMMX (19 years) vs GFACX (24 years). CSMMX (1.73) is less costly to investors than GFACX (1.36). CSMMX is a more actively managed with annual turnover of: 57.00 vs. GFACX (25.00). GFACX has a lower initial minimum investment than CSMMX: GFACX (250) vs CSMMX (1000). CSMMX annual gain was more profitable for investors over the last year : -0.46 vs. GFACX (-1.75). GFACX return over 5 years is better than : 59.73 vs. CSMMX (28.46).
CSMMXGFACXCSMMX / GFACX
Total Expense Ratio1.731.36127%
Annual Report Gross Expense Ratio1.731.36127%
Fund Existence19 years24 years-
Gain YTD-12.623-5.003252%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets3.08B280B1%
Annual Yield % from dividends0.000.00-
Returns for 1 year-0.46-1.7526%
Returns for 3 years-1.160.63-184%
Returns for 5 years28.4659.7348%
Returns for 10 years19.8944.4645%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OTLY9.54-0.41
-4.12%
Oatly Group AB
INDP0.47-0.03
-5.24%
Indaptus Therapeutics
VTRS8.16-0.50
-5.77%
Viatris
GDRX4.29-0.28
-6.13%
GoodRx Holdings
KOD2.40-0.27
-10.11%
Kodiak Sciences